Select language
Endorsing Organizations
Meet the organisations endorsing the Cardiovascular, Renal, Metabolic, Liver and Obesity 2026 Conference.
About CaReMeLO
Cardiac disease, chronic kidney and liver disease and metabolic derangements like type 2 diabetes (T2DM) and their risk factors share etiologies and pathophysiologic mechanisms. These novel insights and their therapeutic implications have been recognized and adopted by cardiology, nephrology and endocrinology alike. Yet a need exists for a multidisciplinary scientific platform that unites all interested parties and serves as a unique gathering, devoting time to in-depth Cardiovascular, Renal, Liver, Metabolic and Obesity discussions.
The conference will continue to spotlight the pivotal role of family physicians in the integrated management of cardio-renal-metabolic (CRM) syndrome, steatotic liver disease, and obesity (CaReMeLO), with an enhanced focus on the SGLT2Inb, GLP-1R agonist and the dual GIPR/GLP-1R agonist.
Conference Highlights
Expanded Sessions
Dedicated tracks on the use of GLP-1 receptor agonists, highlighting their clinical benefits, patient selection, and real-world application in treating obesity.
Expert Insights
Hear from a distinguished panel of speakers, as well as leading family physicians on cardiometabolic health and the role of the family physician.
Innovative Learning
Case-based discussions, interactive workshops, and hands-on training sessions designed to enhance
practical skills.
Collaborative Workshops
Sessions on fostering a multidisciplinary approach to patient care, featuring insights into successful collaboration between family physicians, endocrinologists, cardiologists, nephrologists, and allied health professionals.
Networking
Ample opportunities for
one-on-one interactions,
group discussions, and
partnership development, with
a focus on fostering
collaborations that transcend
national borders within Europe.
Conference Committee
Prof. Avraham Karasik
Founder & Co-Chair of CaReMeLOProfessor of Medicine (Emeritus), Tel Aviv University, Israel
Dr. Baruch
Itzhak
Co-Chair of CaReMeLO
Specialist in Family Medicine, Diabetologist, Clalit Health Services, Technion Faculty of Medicine, Haifa, Israel
Prof. Josep M. Vilaseca
Co-Chair of CaReMeLOGeneral Practitioner/ Family Doctor, University of Vic – Central Catalonia University; Althaia Foundation, Spain
Prof. Eberhard Standl
Co-Chair of CaReMeLOEndocrinologist/ Angiologist, Munich Diabetes Research Group Helmholtz Centre, Germany
Prof. Oliver Schnell
Co-Chair of CaReMeLOFounder and Managing Director of Sciarc GmbH, Munich, Germany
Prof. Thomas Frese
Co-Chair of CaReMeLOPresident of WONCA Europe starting 2025, Director of the Institute of General Medicine, Medical Faculty of Leipzig, Germany
Prof. Shlomo Vinker
Co-Chair of CaReMeLOPresident of WONCA Europe from 2021-2025, Executive board member of EGPRN, Tel Aviv University, Israel
Prof. Jörg Schelling
Co-Chair of CaReMeLOSpecialist in General Medicine, Hausärztliche Gemeinschaftspraxis Martinsried, Germany